New baby formula study aims for better growth and digestion
NCT ID NCT07513506
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study compares a new extensively hydrolyzed casein formula (not yet FDA-approved) to a currently available one in 214 healthy infants aged 10-14 days. Researchers will measure weight gain, length, head size, stool patterns, and tolerance (spit-up, fussiness, gas). The goal is to see if the new formula supports normal growth and is well-tolerated.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
extensively hydrolyzed casein-based infant formula
What this could lead to
If successful, this could provide a new option for infants who need a hypoallergenic formula, supporting normal growth and digestion.
What could go wrong
This is an early-stage study comparing two formulas, not a treatment for a disease. Results may not show significant differences, and individual infant tolerance can vary.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GROWTH are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AMR
Syracuse, Utah, 84075, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
AVIATI Healthcare & Clinical Research
Memphis, Tennessee, 38115, United States
-
Alabama Clinical Therapeutics
Birmingham, Alabama, 35235, United States
-
Alabama Clinical Therapeutics
Birmingham, Alabama, 35235, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Contact
-
Childrens Clinic of Jonesboro
Jonesboro, Arkansas, 72401, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Hope Research Network
Virginia Gardens, Florida, 33166, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
InnovoResearch
Wilmington, North Carolina, 28405, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Mid Valley Research Inc.
Moline, Illinois, 61265, United States
-
NeutraLife Science
Richmond, Texas, 77469, United States
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
SPRIM
Harbor Beach, Florida, 32937, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
Springs Medical Research
Owensboro, Kentucky, 42303, United States
-
Symphony Research
Jacksonville, Florida, 32224, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact